View Exam | PowerPak

1. Atopic dermatitis is most likely to present in which of the following patient populations?

A. Adults (18 to 64 years old) B. Geriatrics (65 years and older) C. Children and adolescents (0 to 17 years old) D. All of the above

2. Which of the following is not part of the nonpharmacologic approach to the treatment of atopic dermatitis?

A. Bathing B. Moisturizing C. Limited use of non-soap cleansers D. Topical corticosteroids

3. Proper bathing technique for patients with atopic dermatitis includes all of the following instructions EXCEPT which of the following?

A. Use warm water B. Use a soap cleanser with a pH greater than 7 C. Do not allow water to evaporate from skin D. Apply moisturizer after bathing

4. Topical calcineurin inhibitors (TCIs) are indicated for which of the following atopic dermatitis (AD) treatment plans?

A. Second-line therapy for children (>2 years old) and adults B. First-line therapy for adults only C. First-line therapy for children (>2 years old) only D. None of the above; TCIs are not approved for treatment of AD in children and adults

5. Which of the following techniques is recommended when applying topical corticosteroids for the treatment of atopic dermatitis?

A. Rule of 9s B. Adult fingertip unit C. The plaque test D. A and B

6. Which of the following are disadvantages of systemic therapies for the treatment of atopic dermatitis compared to topical therapies?

A. Systemic therapies require more monitoring B. Systemic therapies have a higher incidence of adverse drug reactions C. Systemic therapies have an increased risk of drug-drug interactions D. All of the above

7. Which of the following describes the correct dosing regimen and administration of dupilumab?

A. 300 mg weekly by intramuscular injection B. 600 mg once followed by 300 mg every other week by subcutaneous injection C. 300 mg daily by subcutaneous injection D. 600 mg once followed by 300 mg every other week by intramuscular injection

8. The novel agent crisaborole is part of which class of agents?

A. Phosphodiesterase-4 inhibitors B. Interleukin inhibitors C. Immunosuppressants D. Antimetabolites

9.
Use the following patient case for questions 9 and 10:

NG is a 4-year-old male who presents to the pharmacy with his parents to inquire about treatment for a rash. Over the past few weeks, an itchy red rash has developed on his cheeks. He takes a bath every other day; his parents bathe him with a bar of soap and, occasionally, if his skin is dry, they apply a moisturizer after his bath. He has no allergies, no significant past medical history, and his only current medication is a children's chewable multivitamin, which he takes daily.

Which of the following recommendations could you provide to NGs parents?

A. Eliminate detergents and soaps that contain fragrances B. Bathe daily with warm water C. Apply moisturizer daily D. All of the above

10. One month later, NG and his parents return to the pharmacy. They have implemented all the changes you suggested, but the rash has spread to his chest. What is the best advice you can offer NG's parents?

A. Start a daily oral antihistamine B. Start oral ibuprofen as needed for inflammation of rash C. Change to a different moisturizer D. Consult NG's primary care physician

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Atopic dermatitis is most likely to present in which of the following patient populations?

2. Which of the following is not part of the nonpharmacologic approach to the treatment of atopic dermatitis?

3. Proper bathing technique for patients with atopic dermatitis includes all of the following instructions EXCEPT which of the following?

4. Topical calcineurin inhibitors (TCIs) are indicated for which of the following atopic dermatitis (AD) treatment plans?

5. Which of the following techniques is recommended when applying topical corticosteroids for the treatment of atopic dermatitis?

6. Which of the following are disadvantages of systemic therapies for the treatment of atopic dermatitis compared to topical therapies?

7. Which of the following describes the correct dosing regimen and administration of dupilumab?

8. The novel agent crisaborole is part of which class of agents?

10. One month later, NG and his parents return to the pharmacy. They have implemented all the changes you suggested, but the rash has spread to his chest. What is the best advice you can offer NG's parents?

« Return to Activity

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Atopic dermatitis is most likely to present in which of the following patient populations?

2. Which of the following is not part of the nonpharmacologic approach to the treatment of atopic dermatitis?

3. Proper bathing technique for patients with atopic dermatitis includes all of the following instructions EXCEPT which of the following?

4. Topical calcineurin inhibitors (TCIs) are indicated for which of the following atopic dermatitis (AD) treatment plans?

5. Which of the following techniques is recommended when applying topical corticosteroids for the treatment of atopic dermatitis?

6. Which of the following are disadvantages of systemic therapies for the treatment of atopic dermatitis compared to topical therapies?

7. Which of the following describes the correct dosing regimen and administration of dupilumab?

8. The novel agent crisaborole is part of which class of agents?

10. One month later, NG and his parents return to the pharmacy. They have implemented all the changes you suggested, but the rash has spread to his chest. What is the best advice you can offer NG's parents?

« Return to Activity

Customers who Purchased
this Activity also Purchased